ContentEach capsul contains Orlistat 120 mg
Contra IndicationChronic malabsorption syndrome, cholestasis, pregnancy and lactation.
Patients with BMI ≥ 30 mg/m2 or ≥ 27 kg/m2 with associated risk factors : 120 mg tid with each main meal containing fat. Patients with BMI ≥ 28 kg/m2 irrespective of any risk factors : 60 mg tid.
Should be taken with food.
Not recommended in children.
Special PrecautionPatient with history hyperoxaluria or Ca oxalate nephrolithiasis.
Adverse ReactionFaecal urgency or incontinence, flatulence, fatty stools or discharge, headache, anxiety, fatigue, rectal bleeding, menstrual irregularities, leukocytoclactic vasculitis.
Potentially Fatal : Severe liver damage with hepatocellular necrosis or acute hepatic failure.
Drug InteractionEnhanced bioavailability & lipid lowering effect of Pravastin. Decreased absorption of Vit A, D, E, K, and β-carotene. Inhibits absorption of oral fat soluble-nutrients. Warfarin or other anticoagulants. Oral hypoglycemics.
Presentation/PackingBox, 3 blister @ 10 capsul
Store below 25°C